异形多中心卡斯特曼病:诊断和治疗方面的最新进展
1Oncology Hematology Care, 5053 Wooster Road, Cincinnati, OH 45226, USA.
Blood reviews
|December 13, 2023
概括
异形多中心卡斯特曼病 (iMCD) 是一种罕见的,诊断不足的疾病. 最近的进展包括抗IL-6抗体西尔图西马布,改善了这种严重疾病的诊断和治疗.
科学领域:
- 血液学 血液学 血液学
- 免疫学 免疫学 免疫学
- 罕见疾病 罕见疾病
背景情况:
- 异常多中心卡斯特曼病 (iMCD) 是一种罕见的淋巴增殖性疾病.
- 由于异质的临床和实验室发现,诊断具有挑战性.
- iMCD与显著的发病率和死亡率有关.
研究的目的:
- 为提供最近在异常多中心卡斯特曼病的最新发展的最新审查.
- 突出IMCD的诊断和治疗方面的进展.
- 讨论有关iMCD的新出版物.
主要方法:
- 关于iMCD最近出版的文献综述.
- 对诊断标准和治疗策略的分析.
- 综合当前对iMCD病原和管理的理解.
主要成果:
- 在过去的十年中,IMCD诊断和治疗取得了重大进展.
- 批准Siltuximab,一种抗IL-6抗体,作为一个关键的治疗选择.
- 目前正在研究iMCD的根本原因.
结论:
- 尽管面临挑战,但在了解和管理iMCD方面取得的进展是可观的.
- 针对性治疗,如西尔图克西马布为iMCD患者提供了新的希望.
- 持续的研究对于进一步改善iMCD的结果至关重要.
更多相关视频
09:08Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling
Published on: October 14, 2021
5.5K
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
460
相关概念视频
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
174
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
174
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
335
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
335
Cystic Fibrosis: Management
170
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
170
